Both in Pharmaceuticals
Crescent Biopharma vs Evolus
Over the past year CBIO returned +5.7% and EOLS returned +15.3%; their daily moves had a correlation of 0.14.
CBIO +5.7% EOLS +15.3%Growth of $1, one year, split-adjusted
| Metric | CBIO | EOLS |
|---|---|---|
| Price | $13.06 | $7.37 |
| Market cap | $485.1M | $486.8M |
| Today | +1.16% | +2.93% |
| 1 month | −6.3% | −1.3% |
| 6 months | −27.8% | +15.7% |
| Year to date | +10.1% | +10.8% |
| 1 year | +2.4% | +14.1% |
| Revenue growth (YoY) | — | +21.2% |
| Gross margin | — | 68.0% |
| Net margin | — | −9.6% |
| P/E (TTM) | — | — |
| Price / sales | 40.8× | 1.5× |
| Net cash | $171.6M | -$141.9M |
| Dividend yield | — | — |
| Volatility (60d) | 68.9% | 52.8% |
| Short % of float | 21.2% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).